International Journal of Infectious Diseases
Volume 14, Issue 2 , Pages e115-e120 , February 2010

Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia

  • Ziad A. Memish

      Affiliations

    • Department of Infection Prevention and Control, King Abdulaziz Medical City, PO Box 22490, Riyadh 11426, Saudi Arabia
    • Corresponding Author InformationCorresponding author. Tel.: +966 1 2520088x43720; fax: +966 1 2520437.
    • ,
  • Bandar Al Knawy

      Affiliations

    • Division of Gastroenterology/Hepatology, Department of Internal Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia
    • ,
  • Aiman El-Saed

      Affiliations

    • Department of Infection Prevention and Control, King Abdulaziz Medical City, PO Box 22490, Riyadh 11426, Saudi Arabia

Received 15 February 2009 ,Revised 25 March 2009 ,Accepted 29 March 2009.

References 

  1. Ministry of Health of Saudi Arabia. A review of health situation. The annual health statistics book. Saudi Arabia: Ministry of Health; 2007. Available at: http://www.moh.gov.sa/statistics/index.html.(accessed May 2009).
  2. Al-Sebayel M, Khalaf H, Al-Sofayan M, Al-Saghier M, Abdo A, Al-Bahili H, et al. Experience with 122 consecutive liver transplant procedures at King Faisal Specialist Hospital and Research Center. Ann Saudi Med. 2007;27:333–338
  3. Ayoola EA, Gadour MO. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection. J Gastroenterol Hepatol. 2004;19:665–669
  4. Mansoor I. Experience of liver disease at a University Hospital in Western Saudi Arabia. Saudi Med J. 2002;23:1070–1073
  5. Andre F, Hepatitis B. epidemiology in Asia, the Middle East and Africa. Vaccine. 2000;18(Suppl 1):S20–S22
  6. Madani TA. Trend in incidence of hepatitis B virus infection during a decade of universal childhood hepatitis B vaccination in Saudi Arabia. Trans R Soc Trop Med Hyg. 2007;101:278–283
  7. Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hamza MK, Ageel AM. The decline of hepatitis B viral infection in southwestern Saudi Arabia. Saudi Med J. 2003;24:991–995
  8. Al-Faleh FZ. Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades. Ann Saudi Med. 2003;23:367–371
  9. Shobokshi OA, Serebour FE, Al-Drees AZ, Mitwalli AH, Qahtani A, Skakni LI. Hepatitis C virus seroprevalence rate among Saudis. Saudi Med J. 2003;24(Suppl 2):S81–S86
  10. Karkar A, Hepatitis C. in dialysis units: the Saudi experience. Hemodial Int. 2007;11:354–367
  11. Bashawri LA, Fawaz NA, Ahmad MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clin Lab Haematol. 2004;26:225–228
  12. Madani TA, Hepatitis C. virus infections reported in Saudi Arabia over 11 years of surveillance. Ann Saudi Med. 2007;27:191–194
  13. Tufenkeji H, Hepatitis A. shifting epidemiology in the Middle East and Africa. Vaccine. 2000;18(Suppl 1):S65–S67
  14. Almuneef MA, Memish ZA, Balkhy HH, Qahtani M, AlOtaibi B, Hajeer A, et al. Epidemiologic shift in the prevalence of hepatitis A virus in Saudi Arabia: a case for routine hepatitis A vaccination. Vaccine. 2006;24:5599–5603
  15. Al-Tawfiq JA, Anani A. Profile of viral hepatitis A, B, and C in a Saudi Arabian hospital. Med Sci Monit. 2008;14:CR52–CR56
  16. World Health Organization. Department of Vaccines and Biologicals. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Geneva: World Health Organization; 2003. Available at: http://www.who.int/vaccines-documents/DocsPDF06/843.pdf.(accessed May 2009).
  17. Al-Faleh FZ, Al-Jeffri M, Ramia S, Al-Rashed R, Arif M, Rezeig M, et al. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J Infect. 1999;38:167–170
  18. Wasley A, Grytdal S, Gallagher K . Centers for Disease Control and Prevention. Surveillance for acute viral hepatitis—United States, 2006. MMWR Surveill Summ. 2008;57:1–24
  19. Bauduceau O, Berlioz A, Buisson Y. [Hepatitis B, C, and E in New Caledonia. Seroepidemiologic study in military recruits]. Med Trop (Mars). 2000;60:167–170
  20. Memish Z, Qasim L, Abed E, AlBasheer A, Aldraihim A, Knawy B, et al. Pattern of viral hepatitis infection in a selected population from Saudi Arabia. Mil Med. 2003;168:565–568
  21. Franco E, Giambi C, Ialacci R, Coppola RC, Zanetti AR. Risk groups for hepatitis A virus infection. Vaccine. 2003;21:2224–2233
  22. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the central region of Saudi Arabia. Saudi Med J. 2004;25:26–33
  23. Mehdi SR, Pophali A, Al-Abdul Rahim KA. Prevalence of hepatitis B and C and blood donors. Saudi Med J. 2000;21:942–944
  24. Al Rashed RS. Prevalence of hepatitis A virus among Saudi Arabian children: a community-based study. Ann Saudi Med. 1997;17:200–203
  25. Suslov IM, Tkachenko GM, Kalenchuk AA, Astakhov AS. [Epidemiological analysis of hepatitis A morbidity]. Zh Mikrobiol Epidemiol Immunobiol. 1988;39–43
  26. Battikhi MN, Battikhi EG. The seroepidemiology of hepatitis A virus in Amman. Jordan. New Microbiol. 2004;27:215–220

PII: S1201-9712(09)00187-8

doi: 10.1016/j.ijid.2009.03.027

International Journal of Infectious Diseases
Volume 14, Issue 2 , Pages e115-e120 , February 2010

Article Tools

* Image Usage & Resolution